SITC Archive Library

SITC 2017 Annual Meeting: Session 106: High Impact Clinical Trial Results 

11-21-2017 11:39

The Society for Immunotherapy of Cancer (SITC) hosted "Session 106: High Impact Clinical Trial Results" during the SITC 2017 Annual Meeting on November 10, 2017. Available here are the presentation slides and video from the session.

Program Organizers

  • Chair: Mario Sznol, MD – Yale School of Medicine
  • Charlie Garnett Benson, PhD – Georgia State University
  • Elizabeth A. Repasky, PhD – Roswell Park Cancer Institute

Program Summary

The Society for Immunotherapy of Cancer's (SITC) 32nd Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy. This session highlights the key clinical trial results and findings.

Intended Audience

The audience included U.S. and international researchers, regulators and healthcare professionals involved in cancer research and clinical care. This included, but was not limited to basic, translational and clinical researchers; postdoctoral fellows; oncologists; registered nurses; nurse practitioners; pharmacists; payers; and other allied health professionals.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#ClinicalTrials#PresentationSlides#Video#AnnualMeeting#SITC
#CombinationTherapy#AlliedHealth#Clinician#Industry#Researcher
#2017#Melanoma#RenalCellCarcinoma#Cytokines#Nivolumab#Ipilimumab
#TherapeuticAntibodies#AdverseEvents#NonSmallCellLungCancer

Statistics
0 Favorited
189 Views
8 Files
0 Shares
342 Downloads
Attachment(s)
pdf file
"Nivolumab + Ipilimumab (N+I) vs Sunitinib (S) for Treatm...   960 KB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter: Robert J. Motzer, MD – Memorial Sloan Kettering Cancer Center; Date: November 10, 2017
mp4 file
"Nivolumab + Ipilimumab (N+I) vs Sunitinib (S) for Treatm...   231.08 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter: Robert J. Motzer, MD – Memorial Sloan Kettering Cancer Center; Date: November 10, 2017
pdf file
"Immune and Tumor Responses to Human IL-10 (AM0010, Pegil...   4.81 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter: Martin Oft, MD – ARMO BioScience; Date: November 10, 2017
mp4 file
"Immune and Tumor Responses to Human IL-10 (AM0010, Pegil...   207.54 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter: Martin Oft, MD – ARMO BioScience; Date: November 10, 2017
pdf file
"A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Ant...   3.22 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter: Glen J. Weiss, MD – Western Regional Medical Center Inc.; Date: November 10, 2017
mp4 file
"A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Ant...   130.18 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter: Glen J. Weiss, MD – Western Regional Medical Center Inc.; Date: November 10, 2017
pdf file
"Expert Discussant" - Presentation Slides   2.25 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter: Samir Khleif, MD – Georgia Cancer Center; Date: November 10, 2017
mp4 file
"Expert Discussant" - Video   183.21 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Session 106: High Impact Clinical Trial Results; Presenter Samir Khleif, MD – Georgia Cancer Center; Date: November 10, 2017